Regenerative Biologics Supplier for Buffalo Medspas and Dermatology

Medspas Operate Under a Supervising Physician's Account

Medical spas that are not themselves a physician practice generally need a supervising or medical director physician to hold the verified Precision Biologics account, since accounts require a National Provider Identifier checked against NPPES.

Dermatology and plastic surgery practices that are already physician-owned can typically apply directly under the treating physician's own NPI.

What Gets Requested Before an Aesthetic Practice Orders

Aesthetic practices commonly request the same base documentation as any other specialty: certificate of analysis, donor eligibility summary and, for exosome products, the supplier's reported characterization data and growth-factor and cytokine panel, presented strictly as analytical findings rather than claims about effect.

Full ingredient disclosures for lyophilized exosome products such as Bio EX and Bio AER are provided to verified accounts rather than published, consistent with how these formats are documented across the supplier's catalog.

Shipping to a Northeast Aesthetic Practice

Cryopreserved Wharton's jelly formats ship overnight on dry ice and must move into -80 degree Celsius storage promptly on arrival, which medical spas without existing cold-chain equipment should plan for before ordering a cryopreserved format.

Lyophilized exosome products are shelf-stable without refrigeration under normal storage conditions, which is often a more practical starting point for a practice setting up cold-chain capability for the first time.

Verifying Licensure and Scope Before Ordering

Precision Biologics asks every practice to verify its own licensure and supervising-physician arrangement with the New York State Board for Medicine and, where applicable, the state boards governing nursing or physician assistant practice, and to review scope-of-practice questions with counsel rather than with Precision Biologics.

Precision Biologics' role in account setup is limited to NPI verification, providing requested documentation and arranging a physician-level call about that documentation.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.